TRUNEXUS
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
What this record means
The record shows that the application for “TRUNEXUS” filed by Elanco US Inc. on Jan 03 2019 is now dead; it was abandoned on Aug 08 2022 because no Statement of Use was filed after the Notice of Allowance. The goods listed are limited to class 005 pharmaceuticals for animals, including veterinary vaccines, antimicrobial preparations, reproductive enhancers, biopharmaceuticals, medicated feed, ectoparasiticides, insecticides, parasiticides, and hormone preparations. A similar name used in the same animal‑health space would be the closest record‑based concern, while uses outside those veterinary pharmaceutical categories fall farther from the scope shown. The prosecution history records multiple extensions of time to file a Statement of Use, but none resulted in a registration, and the mark never entered the Supplemental Register. The latest meaningful event is the abandonment notice on Aug 08 2022, and the supplied history shows no oppositions, cancellations or other enforcement actions. I'd treat this as a notable concern if you plan a comparable name in animal‑health products.
Informational only - not legal advice.Mark Trademark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Jan 03, 2019 |
| Published for opposition | May 07, 2019 |
| Notice of Allowance | Jul 02, 2019 |
| Status date | Aug 08, 2022 |
Goods & services
Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock; veterinary preparations for enhancing reproduction in livestock; immunorestorative biopharmaceuticals for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; veterinary hormone preparations and hormone preparations in the nature of biological implants for animals, namely, progesterone, estrogen and testosterone; veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat; veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders; veterinary preparations for companion animals for nonsurgical sterilization, namely, hormones for the control and prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals including horses; veterinary preparations to control infectious diseases and parasites in fish, namely, vaccines, parasiticides and insecticides
Owner & representation
| Owner | Elanco US Inc. |
| Address | 2500 Innovation Way, Greenfield, INDIANA UNITED STATES 46140 |
| Entity | CORPORATION - organized in DELAWARE |
| Attorney of record | Caleb Norris |
| Correspondent | Caleb Norris |
| Attorney email | m********@*****.com |
| Correspondent email | 2 emails |
| Correspondent phone | 8********0 |
| Correspondent address | Buffalo Grove, ILLINOIS |